Role of neoadjuvant treatment in clinical T2N0M0 oesophageal cancer: results from a retrospective multi-center European study. Markar SR, Gronnier C, Pasquer A, Duhamel A, Beal H, Théreaux J, Gagnière J, Lebreton G, Brigand C, Meunier B, Collet D, & Mariette C Eur. J. Cancer, 56:59-68, 2016.
Role of neoadjuvant treatment in clinical T2N0M0 oesophageal cancer: results from a retrospective multi-center European study [link]Paper  doi  bibtex   
@article{markar_sr_role_2016,
title = {Role of neoadjuvant treatment in clinical T2N0M0 oesophageal cancer: results from a retrospective multi-center European study},
volume = {56},
issn = {0959-8049},
url = {http://www.ncbi.nlm.nih.gov/pubmed/26808298},
DOI = {10.1016/j.ejca.2015.11.024},
Language = {English},
Journal = {Eur. J. Cancer},
author = {{Markar SR} and {Gronnier C} and {Pasquer A} and {Duhamel A} and {Beal H} and {Théreaux J} and {Gagnière J} and {Lebreton G} and {Brigand C} and {Meunier B} and {Collet D} and {Mariette C}},
year = {2016},
keywords = {Adenocarcinoma/mortality, Adenocarcinoma/pathology, Adenocarcinoma/therapy*, Carcinoma, Squamous Cell/mortality, Carcinoma, Squamous Cell/pathology, Carcinoma, Squamous Cell/therapy*, Chemoradiotherapy, Adjuvant*/adverse effects, Chemoradiotherapy, Adjuvant*/mortality, Chemotherapy, Adjuvant, Chi-Square Distribution, Disease-Free Survival, Esophageal Neoplasms/mortality, Esophageal Neoplasms/pathology, Esophageal Neoplasms/therapy*, Esophagectomy*/adverse effects, Esophagectomy*/mortality, Europe, Female, Humans, Incidence, Kaplan-Meier Estimate, Logistic Models, Lymphatic Metastasis, Male, Middle Aged, Neoadjuvant Therapy*/adverse effects, Neoadjuvant Therapy*/mortality, Neoplasm Staging, Propensity Score, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome},
pages = {59-68}
}
Downloads: 0